Skip to main content
. 2020 Apr 16;21(8):2773. doi: 10.3390/ijms21082773
5-FU 5-fluorouracil
4E-BP1 eIF4E binding protein-1
AKT
ara-c
ASK1
Protein kinase B
Cytosine arabinoside
Apoptosis signal-regulating kinase 1
ATM Ataxia-telangiectasia mutated
CFZ Carfilzomib
CPT-11 Irinotecan/Camptothecin-11
eIF4E Eukaryotic translation initiation factor 4E
ERK1/2 Extracellular signal-regulated-1/2-ER2
FOLFOX Folinic acid, 5-fluorouracil, Oxaliplatin
HIF-1α Hypoxia-inducible factor 1-alpha
HuR Hu antigen R
MAPKK/MKK Mitogen-activated protein kinase kinase
MEKK3 Mitogen-activated protein kinase kinase kinase 3
MKP-1 Mitogen-activated protein kinase 1
MKNK1 MAPK-interacting kinase 1
OM Oxymatrine
mTOR Mammalian phosphorylation target of rapamycin
p70S6K Ribosomal protein S6 kinase
PAI-1 Plasminogen activator inhibitor 1
PCNA Proliferating Cell Nuclear Antigen
PFS Progression-free survival
PP2AC Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
PXR Pregnane X receptor
RT Radiotherapy
SAPK/JNK c-Jun N-terminal kinases
SN-38 7-etil-10-idrossi-camptotecina
SMAD Small mother against decapentaplegic
TGFβ-1 Transforming growth factor beta 1
TP53 Tumor protein p53
TPL2 Tumor progression locus 2